Stocks
Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -939.4 | -771.1 | -709.1 | -894.4 | -228.1 | -195.4 | ||
| Changes by years, y/y, % | +12% | -18% | -8% | +26% | -74% | -22.9% | |||
Alnylam Pharmaceuticals. EBITDA US GAAP, bln rub
Alnylam Pharmaceuticals. EBITDA US GAAP, changes, %
Alnylam Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -143.4 | -244.2 | 181.6 | -102.9 | -29.9 | -195.4 | |
| Changes by years, y/y, % | +1% | +45% | -177% | -42% | -79% | |||
| Changes by quarters, q/q, % | -19% | +70% | -174% | -157% | -71% | |||
